Seres Therapeutics Inc Free Cash Flow Generation Index

Latest as of September 2025: 1.00x

Seres Therapeutics Inc free cash flow generation index. Seres Therapeutics Inc (MCRB) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $2.20 Million represents 1% of operating cash flow ($2.21 Million).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$2.20 Million
USD

Operating Cash Flow

$2.21 Million
USD

Capital Expenditures

$8.00K
USD

Free Cash Flow Generation Index of Seres Therapeutics Inc (2016–2025)

Free cash flow generation index of Seres Therapeutics Inc from 2016 to 2025. Historical FCF Generation Index trend for Seres Therapeutics Inc across 3 annual periods. See how financially flexible is Seres Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.

Seres Therapeutics Inc Free Cash Flow Generation Index by Year (2016–2025)

Seres Therapeutics Inc free cash flow generation index by year from 2016 to 2025. Year-by-year Free Cash Flow Generation Index for Seres Therapeutics Inc. For the full cash flow conversion analysis, see Seres Therapeutics Inc cash flow conversion.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 0.77x $865.00K $1.12 Million $252.00K ▲ +280.0%
2021 -0.43x $-2.88 Million $6.69 Million $9.57 Million ▼ -184.3%
2016 0.51x $22.43 Million $43.92 Million $21.49 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).